Infrequent tacrolimus-induced nephrotoxicity in French patients with steroid-dependent nephrotic syndrome

Jean Daniel Delbet1,2, Bilal Aoun3, David Buob2,4

  • 1Department of Pediatric Nephrology, Armand Trousseau Hospital, APHP, 26 Avenue du Docteur Arnold Netter, 75012, Paris, France.

Insights

Calcineurin inhibitors (CNI) rarely caused chronic kidney damage in children with severe idiopathic nephrotic syndrome (INS). Kidney biopsies may help detect CNI-induced lesions in patients needing long-term treatment.

Area of Science:

  • Pediatric Nephrology
  • Pharmacology
  • Immunosuppression

Background:

  • Calcineurin inhibitors (CNI) are crucial for treating severe idiopathic nephrotic syndrome (INS) in children.
  • Chronic nephrotoxicity with irreversible lesions is a significant concern with CNI therapy.
  • Identifying risk factors and monitoring for CNI-induced kidney damage is essential.

Purpose of the Study:

  • To evaluate the incidence of chronic CNI-induced nephrotoxicity in children with steroid-dependent INS.
  • To assess the utility of kidney biopsies in detecting CNI-induced lesions in this patient population.
  • To inform treatment strategies and long-term management of pediatric INS.

Main Methods:

  • Retrospective study of children with steroid-dependent INS on CNI for over one year.
  • Inclusion of patients where CNI could not be substituted with mycophenolate mofetil.
  • Analysis of kidney biopsy findings, clinical data, and treatment duration.

Main Results:

  • Twenty-one children were included, with a median CNI treatment duration of 30 months.
  • Minimal change disease was diagnosed in 20/21 patients; focal segmental glomerulosclerosis in 1/21.
  • Chronic CNI-induced nephrotoxicity was infrequent, observed in only one patient (arteriolar hyalinosis and fibrosis).

Conclusions:

  • CNI-induced chronic nephrotoxicity was uncommon in this cohort of children with INS.
  • Kidney biopsies are valuable for excluding chronic CNI-induced lesions in patients requiring long-term or high-dose CNI therapy.
  • This study supports careful monitoring and judicious use of CNIs in pediatric nephrotic syndrome.
Abstract

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
511
Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Here, we describe the induction of experimental nephrotic syndrome in 129S1/SvImJ mice by rapid retrobulbar injection of doxorubicin. We also treat nephrotic mice with sustained release pellets containing aprotinin to inhibit urinary serine protease activity and prevent sodium...
8.8K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
207
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
283
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Here we describe a high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay to quantify the immunosuppressant tacrolimus in dried blood spots using a simple manual protein precipitation step and online column...
17.4K
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Here, we present a protocol for the generation of induced pluripotent Stem Cells (iPSCs) from Li-Fraumeni Syndrome (LFS) patient derived fibroblasts, differentiation of iPSCs via mesenchymal stem cells (MSCs) to osteoblasts, and modeling in vivo tumorigenesis using LFS patient-derived osteoblasts.
9.3K